Guanine nucleotide exchange factors (GEFs) play important roles in many cellular processes, including regulation of the structural plasticity of dendritic spines. A GEF protein, adenomatous polyposis coli-stimulated GEF 1 (Asef1, ARHGEF4) is highly expressed in the nervous system. However, the function of Asef1 has not been investigated in neurons. Here, we present evidence showing that Asef1 negatively regulates the synaptic localization of postsynaptic density protein 95 (PSD-95) in the excitatory synapse by inhibiting Staufen-mediated synaptic localization of PSD-95. Accordingly, Asef1 expression impairs synaptic transmission in hippocampal cultured neurons. In addition, neuronal activity facilitates the dissociation of Asef1 from Staufen in a phosphoinositide 3 kinase (PI3K)-dependent manner. Taken together, our data reveal Asef1 functions as a negative regulator of synaptic localization of PSD-95 and synaptic transmission. Keywords: Asef1, dendritic plasticity, PSD-95, Staufen, synaptic transmission. Abbreviations used: AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ANOVA, analysis of variance; Asef1, adenomatous polyposis coli-stimulated guanine nucleotide exchange factor 1; CaMKII, Ca 2+ /calmodulin-dependent protein kinase II; DAPI, 4',6-diamidino-2-phenylindole; FMRP, fragile X mental retardation protein; GEF, guanine nucleotide exchange factor; GFP, green fluorescent protein; HEK, human embryonic kidney; mEPSC, miniature excitatory postsynaptic current; NMDA, N-methyl-D-aspartate; PI3K, phosphoinositide 3-kinase; PLA, proximity ligation assay; PSD-95, postsynaptic density protein 95; shRNA, small hairpin ribonucleic acid; siRNA, small interfering ribonucleic acid; Stau, Staufen; TRITC-phalloidin, tetramethylrhodamine B isothiocyanate-conjugated phalloidin.
morphological changes in the dendrites (Negishi and Katoh 2005) . A variety of guanine nucleotide exchange factors (GEFs) can activate small GTPases by facilitating the release of GDP from the inactive GDP-bound form of GTPases and allowing GTP to take its place. Therefore, GEFs play a fundamental role in many cellular processes, including regulation of the structural plasticity of dendritic spines, which is one of the cellular bases of learning and memory. Activated Cdc42 and Rac1 participate in spine morphogenesis and maintenance, whereas RhoA has the opposite effect (Penzes and Jones 2008; Sarowar et al. 2016) .
Adenomatous polyposis coli (APC)-stimulated GEF (Asef1, also called ARHGEF4) was initially identified as a linker protein connecting the tumor suppressor APC with G-protein signaling (Kawasaki et al. 2000) . Asef1 is highly expressed in the brain (Hamann et al. 2007) and is a specific GEF for Cdc42 (Gotthardt and Ahmadian 2007; Mitin et al. 2007) . Asef1 contains the APC-binding region (ABR), a Dbl homology (DH) domain responsible for GEF activity, a Pleckstrin homology (PH) domain for interaction with its partners, and a Src homology 3 (SH3) domain (Akiyama and Kawasaki 2006) . The GEF activity of Asef1 is induced by the binding of APC to its N-terminus (Akiyama and Kawasaki 2006) . The role of Asef1 has been widely studied in cellular processes, such as cell migration (Kawasaki et al. 2009 ) and angiogenesis (Kawasaki et al. 2010 ) in various cancer cell types. However, Asef1's role in neurons was not clear.
Staufen, a double-stranded RNA-binding protein, has multiple functions in mRNA transport (Kiebler et al. 1999; Tang et al. 2001) , translational regulation (Dugre-Brisson et al. 2005) , and RNA decay (Kim et al. 2005) . The role of Staufen in dendritic mRNA transport has been extensively studied because local protein synthesis, which depends on the dendritic or synaptic transport and translation of certain mRNAs, is involved in the synaptic plasticity (Kiebler et al. 1999; Tang et al. 2001; Duchaine et al. 2002; Kim and Kim 2006; Jeong et al. 2007) . Two Staufen proteins have been identified in mammals: Staufen1 (Stau1) and Staufen2 (Stau2) (DesGroseillers and Lemieux 1996; Buchner et al. 1999) . Interestingly, numerous studies report that downregulation of Stau1 or 2 by gene knockout or by RNA interference has profound effects on the structure of dendritic spines. For example, the down-regulation of Stau2 reduces the number of dendritic spines and the postsynaptic density protein 95 (PSD-95) immunoreactivity in dendrites (Goetze et al. 2006) . In addition, loss-of-function of the Stau1 reduces the number of dendritic protrusions and PSD-95-positive puncta (Vessey et al. 2008) . Furthermore, the downregulation of Stau1 with RNA interference changes the morphology of dendritic spines (Lebeau et al. 2008 (Lebeau et al. , 2011 . These suggest that Stau1 and Stau2 might play key roles in dendritic structural plasticity.
In this study, we determined the role and mechanism of Asef1 in regulating synaptic composition and function.
Asef1 over-expression reduced PSD-95 and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors at synapses and reduced synaptic transmission. Asef1 directly interacts with Stau1 at the synapse, which contribute to reduce synaptic expression of PSD-95 by Stau1. Furthermore, neuronal activity facilitates the dissociation of Asef1 from Stau1 in a phosphoinositide 3-kinase (PI3K)-dependent manner, which subsequently allows Stau1 to increase the synaptic expression of PSD-95. Thus, we propose Asef1 as a novel regulator for synaptic function.
Materials and method
Cell culture Dissociated hippocampal neuronal cultures were prepared from 1-day-old pups of Sprague-Dawley rat (Samtako, Osan, Korea; RRID: RGD_70508). The neurons were plated onto poly-D-lysine-coated coverslips at a density of 5000-10000 cells/cm 2 . The cultures were incubated in growth medium (Neurobasal-A supplemented with B-27 and Glutamax-1, Gibco, Rockville, MD, USA; Neurobasal-A: Cat# 10888-022; B-27: Cat# 17504-044; Glutamax-1: Cat# 35050-061) at 37°C, 5% CO 2 for 3-12 days, as previously described (Jeong et al. 2007) . The cultures were performed in accordance with the approved animal protocols and the guidelines of the Institutional Animal Care and Use Committee of Chungbuk National University (CBNUR-1033-16 Technologies, Carlsbad, CA, USA; Cat# D6429) supplemented with 7-10% fetal bovine serum (Life Technologies; Cat# 1600004), and were maintained at 37°C, 5% CO 2 . When the cells were grown to 70-80% confluence, they split for subcultures. When the confluence of subcultures reached to 30-40%, they were used for a transfection. The cell lines were not listed in the database ver. 8.0 of commonly misidentified cell line by the International Cell Line Authentication Committee (ICLAC), but not authenticated in your laboratory.
Plasmid constructs
The full-length cDNA of human Asef1 (hAsef1, ARHGEF4, NM_015320) was amplified with PCR to insert restriction enzyme sites at the ends of the sequence (hAsef1-Bam-S, hAsef1-Hind-A; hAsef1-Hind-S, hAsef1-Bam-A), and the product was inserted at the BamHI/HindIII sites of the pCMV-tag2b vector (Stratagene, La Jolla, CA, USA; Cat# 211172) for FLAG tagging. The PCR product was also inserted at the HindIII/BanHI sites of pEGFP-C1 vector (Clontech, Mountain View, CA, USA; Cat# 6084-1) for GFP tagging. GFP-Asef1 was amplified with PCR (GFP-Mlu-S, hAsef1-Pml-A), and was inserted into the pSinRep5 vector (Invitrogen, Carlsbad, CA, USA) for Sindbis viral expression. DH-PH domains were isolated with PCR amplification (hAsef1-DH-Hind-S, hAsef1-Bam-A) and inserted to the pEGFP-C1 vector (Clontech). GFP-DH-PH was amplified with PCR (GFP-Mlu-S, hAsef1-Pml-A) and inserted to the pSinRep5 vector. Construction of Stau1 and Stau2 expression vectors has been described elsewhere (Nam et al. 2008; Lee et al. 2011) . APC-armadillo repeat regions were amplified from the pCMV-neo-APC vector (Addgene, Cambridge, MA, USA; Cat# 16507) by PCR (hAPC-ARM-Xho-S, hAPC-ARM-R1-A; or hAPC-ARM-R1 (HA)-S, hAPC-ARM-Xho-A), and were inserted at the EcoRI/XhoI sites of the pCS4-3xHA vector (donated by Seok-Cheol Bae, Chungbuk Nat'l University, Cheongju, Korea) for HA tagging. The GFP-tagged PSD-95 vector was donated by Jin-A Lee (Hanam University, Daejeon, Korea). The full-length cDNA of human fragile X mental retardation protein (FMRP, FMR1, NM_002024) was amplified by PCR to insert restriction enzyme sites at the ends of the sequence (FMRP-R1-S, FMRP-Sal-A). All restriction enzymes were purchased from New England Biolabs (Ipswich, MA, USA; BamHI: Cat# R0136; HindIII: Cat# R0104; EcoRI: Cat# R0101; XhoI: Cat# R0146). Primers for PCR were as follows: hAsef1-Bam-S, 5 0 -cgggatccaaccacatgccctgggaa-3 0 ; hAsef1-Hind-A,
RNA interference and PSD-95 particle analysis For measurement of the PSD-95 level after down-regulation of Asef1, cultured hippocampal neurons were transfected with scrambled control small interfering RNA (siRNA) (Ambion, Carlsbad, CA, USA; Cat# 4390843) in 25 nM of final concentration and 1 lg of PSD-95-GFP; siRNA #1 (Ambion; Cat# s153869) and PSD-95-GFP; or siRNA#1, PSD-95-GFP, and hAsef1 constructs at the third day in vitro (DIV3) by using Lipofectamine â 3000 reagent (Life Technologies; Cat# L3000015). After a 7-day incubation, PSD-95 levels in dendrites were scored in secondary or tertiary dendrites with similar diameters.
Sindbis virus expression
Sindbis virus particles were prepared following the protocols set by Invitrogen. For Sindbis virus expression, viruses were added to the culture medium directly and 6-12 h was allowed for expression, depending on the experimental design. 
Coimmunoprecipitation and western blotting

Immunocytochemistry
Cultured neurons were fixed with a fixative (4% paraformaldehyde, 4% sucrose, pH 7.2) on ice for 20 min. Cell membranes were permeabilized in PBT (1XPBS, 0.1% bovine serum albumin, 0.1% Triton X-100) solution for 15 min, or not permeabilized. The cultures were subsequently pre-blocked (1XPBS, 2% bovine serum albumin, 0.08% Triton X-100) for 2 h at 25°C. The primary antibody was added to the pre-block solution, and the cells were treated overnight at 4°C. After washing with PBT, a secondary antibody was added to the culture and incubated for 2 h at 25°C, followed by stringent washing in PBT and phosphate-buffered saline. The immunostained cultures were mounted in slide glass and imaged. Monoclonal anti-PSD-95 antibody (clone 6G6-1C9; Thermo Fisher Scientific; Cat# MA1-045, RRID: AB_325399), polyclonal anti-Synapsin I antibody (Millipore; Cat# AB1543, RRID: AB_2200400), monoclonal anti-Homer 1 antibody (Synaptic Systems, G€ ottingen, Germany; Cat# 160 011, RRID: AB_2120992), and polyclonal anti-GluA1 antibody (Alomone labs, Jerusalem, Israel; Cat# AGC-004, RRID: AB_2039878) were used for staining, each at a dilution of 1 : 200. Cy3-or Cy5-conjugated anti-mouse IgG antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA; Cy3: Cat# 115-165-166, RRID: AB_2338692; Cy5: Cat# 115-175-166, RRID: AB_2338714) was used for PSD-95 and Homer 1 immunostaining at a dilution of 1 : 400, respectively. Cy3-conjugated anti-rabbit IgG antibody (Jackson ImmunoResearch Laboratories; Cat# 111-165-144, RRID: AB_2338006) was used for Synapsin I and GluA1 staining at a dilution of 1:400. For phalloidin staining, fixed neurons were treated with 0.5 lM tetramethylrhodamine B isothiocyanate-conjugated phalloidin (TRITC-phalloidin; Sigma-Aldrich; Cat# P1951, RRID: AB_2315148) for 30 min in phosphate-buffered saline. Chemicals were purchased from SigmaAldrich (paraformaldehyde: Cat# P6148; sucrose: Cat# S0389; Triton X-100: Cat# T9284) and MP Biomedicals (Solon, OH, USA; Cat# 160069).
Proximity ligation assay
Cultured rat hippocampal neurons were infected with Sindbis virus encoding GFP for 9 h and treated with high-K + HEPES-buffered saline (HBS) (60 mM) or normal-K + HBS buffer (5.4 mM) for 10 min, and then incubated for 50 min. For the inhibition of the PI3K signaling pathway, GFP virus-infected neurons were either not pretreated or were pretreated with 30 lM LY303511 (a structural analog and negative control compound of LY294002; Tocris Bioscience, Bristol, UK; Cat# 2418) or 30 lM LY294002 (Tocris Bioscience; Cat# 1130). Next, the neurons were treated with high-K + HBS or normal-K + HBS. The cultures were fixed with a fixative (4% paraformaldehyde, 4% sucrose, pH 7.2). For proximity ligation assay (PLA) with Duolink â In Situ-Fluorescence (Sigma-Aldrich;
Cat# DUO92008), goat polyclonal anti-Asef1 (N-20; Santa Cruz Biotechnology, Dallas, TX, USA; Cat# sc-13275, RRID: AB_2243057) and rabbit polyclonal anti-Stau1 antibodies (Thermo Fisher Scientific; Cat# PA5-21038, RRID: AB_11156804) were used at a dilution of 1 : 100, respectively. All procedures were performed according to the manufacturers' instructions. The nucleus of each neuron was stained with 4',6-diamidino-2-phenylindole (Sigma-Aldrich; Cat# 82040-005). PLA and 4',6-diamidino-2-phenylindole staining signals were visualized with a confocal microscopy (Zeiss 710; Carl Zeiss, Oberkochen, Germany).
Electrophysiological recording
Whole-cell patch-clamp recordings were performed with patch pipettes (resistance of 5-6 MΩ) pulled with a P-97 Flaming/Brown puller (Sutter Instrument, Novato, CA, USA). The extracellular recording solution was composed of 140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM glucose, and 10 mM HEPES (pH 7.4, 300 mOsm). Patch recording pipettes were filled with a solution consisting of the following: 100 mM CsOH, 100 mM Dgluconate, 5 mM NaCl, 20 mM tetraethylammonium chloride (TEA-Cl), 4 mM Mg-ATP, 0.3 mM Na 3 GTP, 3 mM N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium Chloride (QX314), 10 mM HEPES, and 10 mM EGTA (pH 7.2, 290 mOsM). For the recordings of miniature excitatory postsynaptic currents (mEPSCs), 1 mM tetrodotoxin (TTX, Tocris Bioscience; Cat# #1078) and 100 lM picrotoxin (Tocris Bioscience; Cat# 1128) were included in the external solution. Chemicals were purchased from Sigma-Aldrich (NaCl: Cat# S9625; KCl: Cat# P3911; CaCl 2 : Cat# C5080; MgCl 2 : Cat# M9272; glucose: Cat# G9005; HEPES: Cat# H4034; CsOH: Cat# 232041; D-gluconate: Cat# G1951; TEACl: Cat# T2265; Mg-ATP: Cat# A9187; Na 3 GTP: Cat# G8877; QX314: Cat# L5783; EGTA: Cat# E3889). All recordings were performed at room temperature (24°C). Currents were recorded with the Axopatch700B amplifier (Axon Instruments, Union City, CA, USA) and were filtered at 2 kHz. Liquid junction potentials were not corrected. Access resistance was monitored with a 10-ms, 5-mV test pulse, every 2 min. The recording was discarded when the series resistance varied by > 20% during the experiment. Currents were digitized (20 kHz) using the Axon Instruments Digidata 1440A analog-to-digital converter and were recorded on a personal computer using pCLAMP9 (Axon Instruments). Quantal signals were recorded by clamping the neurons to À70 mV. The mEPSCs were detected as spontaneous events with a peak amplitude > 7 pA and were analyzed using commercial software (Mini analysis Version 6.0.3, Synaptosoft, Decatur, GA, USA). Experiments were performed on three different hippocampal culture preparations.
Image analysis All images were acquired by a confocal microscopy (Zeiss 710, Carl Zeiss) and processed using the image analysis software of the NIH ImageJ (ver. 1.47v, Rockville, MD, USA). Dendrites with a similar diameter of the secondary or tertiary dendrites from neurons were selected and used for image analysis. The selected dendrites were straightened by plugins of ImageJ. After subtraction of a background value, the intensities of immunostaining in the straightened dendrites were measured. For protrusion analysis, two straightened dendritic images (GFP and phalloidin staining) were merged into a single image and then 0.5-5 lm of dendritic projections were counted. To measure the number or size of PSD-95 or Synapsin I particles, the straightened dendrites were changed to threshold images, and then analyzed by particle analysis. The colocalization was measured by colocalization threshold. All the image acquisitions and analyses were conducted blindly. The n value in image analysis is the number of dendrites from three to four independent cultures. All data are shown as mean AE standard error of the mean (SEM).
Statistical analysis
The normality of each data was assessed by Kolmogorov-Smirnov test or Shapiro-Wilk normality test. If the data did not follow a Gaussian distribution, a nonparametric analysis was conducted. One-way analysis of variance (ANOVA) or Kruskal-Wallis test was used for the comparison of more than two groups. Post hoc comparisons were conducted using Bonferroni's multiple comparison tests or Dunn's multiple comparison tests. The student's unpaired t-test or Mann-Whitney test was used to reveal statistical differences between two groups. We did not conduct any test for outlier. Statistical analyses were performed by GraphPad Prism ver. 5.0 (GraphPad Software, La Jolla, CA, USA).
Results
Asef1 expression induces dendritic structural changes
To examine the role of Asef1 in dendritic structural plasticity, we expressed GFP or GFP-Asef1 in cultured hippocampal neurons using the Sindbis viral expression system and examined number of dendritic protrusions. As Asef1 was initially identified as an APC-binding protein (Kawasaki et al. 2000) and APC interacts with postsynaptic density protein 95 (PSD-95) through the C-terminal [S/T]-X-[V/L/I] motif (Yanai et al. 2000) , we also examined the level of PSD-95, a postsynaptic marker protein (Cui et al. 2016) , in the dendrites (Fig. 1a and b) . Asef1 expression in the dendrites caused a significant increase in the relative number of dendritic protrusions compared with that in the GFP control group (Fig. 1c) , suggesting that Asef1 is involved in regulating the structural plasticity of dendrites, but simultaneously Asef1 expression significantly reduced the relative intensity and number of PSD-95-immunopositive puncta ( Fig. 1d and e) . Therefore, we examined whether Asef1 is colocalized with PSD-95 in the dendrites of cultured hippocampal neurons and whether its expression affects the synaptic localization of Synapsin I, a presynaptic marker protein. As shown in Figures S1a and b , Asef1-immunopositive puncta were colocalized with those of PSD-95. In contrast with the results of PSD-95 ( Fig. S1c and d) , Asef1 expression did not significantly change the number and average size of Synapsin I-immunopositive puncta in the dendrites (Fig. S1e and f) . Additionally to examine whether Asef1 specifically could down-regulate the postsynaptic localization of PSD-95, we measured the level of Homer 1, another postsynaptic marker protein (Tao-Cheng et al. 2014) . Asef1 expression significantly reduced the level of PSD-95, but had no significant effect on that of Homer 1 (Fig. S2 ).
Asef1 expression reduces postsynaptic function
We next evaluated whether the reduction of PSD-95 by Asef1 expression could also induce functional changes of synaptic transmission of cultured hippocampal neurons (Fig. 2a) . We found that the frequency of mEPSCs significantly reduced in the Asef1-expressing cultured hippocampal neurons compared with that in the GFP-expressing control neurons (Fig. 2b) , suggesting a reduction of presynaptic release probability or in the number of functional synapses. Furthermore, the amplitude of mEPSCs also reduced in Asef1-expressing neurons compared with that in the GFP-expressing control neurons (Fig. 2c) , suggesting a reduction of postsynaptic receptor function. However, the decay time of mEPSCs did not change (Fig. 2d) , indicating no changes in the properties of postsynaptic AMPA decreased the relative number (GFP: 100.00 AE 7.39%, n = 15; Asef1: 76.86 AE 3.82%, n = 16, student's t-test: **p < 0.01) and relative intensity (GFP: 100.00 AE 8.59%, n = 15; Asef1: 75.92 AE 4.23, n = 16, student's t-test: *P < 0.05) of PSD-95 puncta. Data are represented as mean AE SEM. The n value means n dendrites from three to four independent cultures. receptors. In subsequent experiments, we measured the amount of GluA1 clusters on the surface of hippocampal neurons expressing Asef1. Consistent with the reduction in PSD-95 puncta and synaptic transmission, Asef1 expression significantly decreased the number of GluA1-containing AMPA receptors on the cell surface ( Fig. 2e and f) . Taken together, these results suggest that Asef1 is a negative regulator of postsynaptic function.
Down-regulation of Asef1 increases PSD-95 levels in the dendrites
To assess whether endogenous Asef1 could affect synaptic PSD-95 level, we introduced a siRNA specific for rat Asef1 mRNA (Fig. S3) and measured PSD-95-positive particles in the dendrites of cultured hippocampal neurons. Downregulation of endogenous Asef1 increased the number and average size of PSD-95-positive particles in the dendrites, and this effect was reversed by the expression of human Asef1, indicating that down-regulation of Asef1 increased PSD-95 levels in the dendrites (Fig. 3) . Consistently, electrophysiological recordings after knockdown of Asef1 with shRNA showed that both the amplitude and frequency of mEPSCs were increased in Asef1 shRNA-expressing neurons compared with those in the scrambled shRNAexpressing control neurons (Fig. S4) .
Asef1 is associated with Stau1
We hypothesize that Asef1 negatively regulates the synaptic localizations of PSD-95 and AMPA receptors by interacting with other synaptic proteins. Previous studies have suggested that down-regulation of Staufen induced the reduction of dendritic protrusions and PSD-95-positive puncta (Goetze et al. 2006; Vessey et al. 2008) . In our study, Asef1 affected the dendritic structure, and regulated PSD-95 expression and Lower panel: representative mEPSC traces from a GFP or GFP-Asef1-expressing neuron at a holding potential of -70 mV. (b) mEPSC frequencies significantly reduced in the GFP-Asef1-expressing neurons compared with that in the GFP-expressing neurons (GFP: 1.64 AE 0.23 Hz, n = 10 neurons; Asef1: 1.11 AE 0.12 Hz, n = 12 neurons, three independent cultures; student's t-test: *p < 0.05). (c) Peak amplitude of mEPSCs significantly reduced in the GFP-Asef1-expressing neurons compared with that in the GFP-expressing neurons (GFP: 19.94 AE 0.86 pA, n = 10 neurons; Asef1: 16.36 AE 0.82 pA, n = 12 neurons, three independent cultures; student's t-test: **p < 0.01). (d) mEPSC decay time was not different between the GFP and GFP-Asef1-expressing neurons (GFP: 3.94 AE 0.21 ms, n = 10 neurons; Asef1: 3.98 AE 0.28 ms, n = 12 neurons, three independent cultures; ns: not significant). (e) Number of GluA1-immunopositive puncta on the surface of GFP-Asef1-expressing neurons significantly reduced compared with that on the surface of GFP-expressing neurons. Scale bar: 20 lm. (f) Quantification of surface GluA1-immunopositive puncta (GFP: 12.4 AE 1.03, n = 18, total length examined: 1617 lm; Asef1: 7.97 AE 1.12, n = 22, total length examined: 2052 lm; student's t-test: **p < 0.01). The n value means n dendrites from three to four independent cultures. localization (Figs 1-3) . Therefore, we investigated whether Asef1 interacts with Staufen, and whether it affects dendritic morphology or synaptic function in the dendrites. First, to test whether Asef1 interacts with Staufen, we performed a co-IP assay using the lysates of HEK 293T cells expressing the Myc-tagged Stau1 or Stau2, and the FLAG-tagged Asef1. We found that both Stau1 and 2 had a strong interaction with Asef1 (Fig. 4a) . In order to identify the interacting regions, we constructed a series of truncated Asef1 mutants (Fig. S5a) and examined their ability to interact with Stau1 by co-IP assays. As shown in Fig. S5 , all C-terminally truncated mutants (ABR, ABR-SH, and DPH) of Asef1 interacted with Stau1, but not the N-terminally truncated mutant, DH-PH (Fig. S5c) . This indicates that the APC-binding region (ABR) of Asef1 was sufficient for the interaction with Stau1. We also examined which regions of Stau1 are involved in the binding with Asef1. As shown in Fig. S5d , the N-terminal RNA-binding domains of Stau1 were involved in the direct interaction with Asef1, which was verified with an in vitro binding assay (Fig. S5e) . In addition, to examine the specificity of interaction between Asef1 and Stau1, we investigated an interaction between Asef1 and fragile X mental retardation protein (FMRP), another RNA-binding protein. As shown in Fig. S5f , we were not able to find any interaction between Asef1 and FMRP.
Next, we examined whether Asef1 colocalizes with Stau1 in cultured hippocampal neurons. As shown in Fig. S6 , nearly 60% of Stau1-positive puncta were also immunopositive for Asef1, and 44% of Asef1-positive puncta were immunopositive for Stau1. In addition, we found colocalization of Asef1 and Stau1 in the dendrites using PLA (Fig. 4b and c) (Sundqvist et al. 2013) . These results suggest that Asef1 is specifically associated with Stau1.
Asef1 inhibits the Staufen-mediated synaptic localization of PSD-95
Next, we examined whether the dendritic level of PSD-95 is regulated by Stau1 expression. Stau1 expression increased the relative intensity and average size (Fig. 5a-d ) of PSD-95-immunopositive puncta in distal dendrites (51-100 lm of dendritic regions from the soma) of cultured hippocampal neurons, suggesting that Staufen positively regulates the synaptic localization of PSD-95. To investigate the effect of Asef1 expression on Stau1's function, we used the PSD-95 clustering assay in COS7 cells (Kim et al. 1995; Poulopoulos et al. 2009 ). We cotransfected COS7 cells with a GFP- 100.00 AE 5.27%, n = 38, total length examined: 4,747 lm; siRNA #1: 128.30 AE 8.24%, n = 35, total length examined: 3793 lm; siRNA #1 + hAsef1: 100.90 AE 6.60%, n = 33, total length examined: 3897 lm; one-way ANOVA: F 2,105 = 5.654, p = 0.0047; Bonferroni's multiple comparison tests: *p < 0.05, **p < 0.01, ns: not significant) and average size (CTL: 100.00 AE 3.99%, n = 38; siRNA #1: 114.90 AE 4.22%, n = 35; siRNA #1 + hAsef1: 95.15 AE 5.00%, n = 33; one-way ANOVA: F 2,105 = 5.360, p = 0.0061; Bonferroni's multiple comparison tests: *p < 0.05, **p < 0.01, ns: not significant) of PSD-95 particles. The n value means n dendrites from three to four independent cultures. tagged PSD-95 (PSD-95-GFP), Stau1, and/or Asef1 constructs, and then measured the area of PSD-95-positive foci. The PSD-95 expression-only (CTL) produced PSD-95 clustered particles covering around 3% of the total cell area ( Fig. 5e and f) . However, Stau1 expression increased the area of PSD-95 particles by 129.2%. Intriguingly, coexpression of Asef1 with Stau1 reversed this effect and significantly reduced the PSD-95 area. Thus, to further investigate whether the reduction of PSD-95 in dendrites by Asef1 is dependent on its binding with Stau1, we expressed PSD-95-GFP, Stau1, and DH-PH mutant of Asef1, which does not have Stau1-binding regions (Fig. S5a and c) . The co-expression of DH-PH mutant did not reduce the PSD-95 area, indicating the necessity of Asef1 binding with Stau1 for the reduction of PSD-95 level (Fig. 5e and f) . Next, we examined PSD-95 level by DH-PH mutant expression in dendrites of cultured hippocampal neurons. As expected, the expression of wild-type Asef1 significantly reduced the relative number and intensity of PSD-95-immunopositive puncta, but DH-PH did not affect those (Fig. 6) . Furthermore, we found that PSD-95 interacted with Stau1 and this interaction was enhanced by wild-type or ABR-SH mutant expression of Asef1, but not by DH-PH mutant expression, indicating the formation of Asef1-Stau1-PSD-95 complexes (Fig. S7) . Taken together, these results suggest that Asef1 reduces PSD-95 expression by inhibiting Staufen's ability to localize PSD-95 in synaptic regions.
Neuronal activity regulates binding of Asef1 to Stau1
To elucidate a regulatory mechanism of interaction between Asef1 and Stau1, we investigated whether the interaction is regulated by neuronal activity. To activate the neurons, we added a high-K+ buffer (60 mM KCl) to the neuronal cultures and monitored the colocalization of Asef1 and Stau1 using PLA. Interestingly, neuronal activity significantly reduced the relative number of PLA-positive particles, indicating decreased interaction between Asef1 and Stau1 in the dendrites (Fig. 7a and  b) . Furthermore, the PLA signal intensity was significantly lower in the high-K + buffer-treated dendrites than in the regularly buffered dendrites (Fig. 7a-c) . Next, we investigated the signaling pathway involved in the neuronal activity-dependent dissociation of Asef1 from Stau1. Previous studies have shown that PI3K activation requires membrane localization of AMPA receptors and synaptic localization of PSD-95 (Man et al. 2003) , which might require Asef1-free Stau1. Therefore, we examined the interaction between the two proteins following neuronal activation while inhibiting the PI3K activity. PI3K inhibitor (LY294002) significantly blocked the neuronal activity-induced dissociation of Asef1 from Stau1 (Fig. 7d) . This suggests that the association of Asef1 and Stau1 might be regulated by neuronal activity and might be dependent on the PI3K signaling pathway.
Discussion
In our experiments, we found that Asef1 expression induced not only an increase in dendritic protrusions but also a decrease in the PSD-95 level in the dendrites and synaptic transmission (Figs 1 and 2 , and S1). Many GEFs are localized to synaptic regions and are associated with postsynaptic scaffolding proteins to regulate structural and functional plasticity of dendrites (Garcia-Mata and Burridge 2007). The Kalirin-7 GEF interacts with PSD-95 through its C-terminal PSD-95, Dlg [discs large homolog], and ZO-1 [zona occludens or tight junction] domain (PDZ) and plays a key role in dendritic spine morphogenesis and plasticity (Rabiner et al. 2005; Penzes and Jones 2008) . Synaptic activity induces the phosphorylation of Kalirin-7, which is mediated by Ca 2+ /calmodulin-dependent protein kinase II and the subsequent Rac1-dependent increase in AMPA receptors. In addition, down-regulation of Kalirin-7 induces a significant decrease in PSD-95-positive puncta in dendrites ( (Ma et al. 2003; Rabiner et al. 2005) . Furthermore, interaction with PSD-95 maintains the postsynaptic localization of Kalirin-7 and decreases its GEF activity (Garcia-Mata and Burridge 2007) . Interestingly, the binding of Stau1 to Asef1 has the opposite effect compared with that of Kalirin-7-PSD-95 interaction on the dendritic spines (Figs 1 and 2 , and S1).
The physiological role of Asef1 might be regulated by the nature of binding partners and/or the cellular localization of Asef1. It has been reported that N-cadherin-catenin complexes in neurons play a key role in synaptic assembly and plasticity (Salinas and Price 2005; Takeichi and Abe 2005) . Recently, it was found that d-catenin increases the number of dendritic protrusions following neuronal activation, which decreases the association of d-catenin and N-cadherin (AbuElneel et al. 2008) . Furthermore, neuronal activation increases the amount of b-catenin in the dendritic spines, thereby increasing the number of dendritic protrusions (Murase et al. 2002) . In our study, the depolarizationinduced neuronal activation decreased the association of Asef1 with Stau1 (Fig. 7) , which might allow activated APC and/or b-or d-catenin to bind Asef1 and activate Asef1's GEF activity. Furthermore, as shown in Figure S7 , the 100.00 AE 7.71%, n = 29; Asef1: 75.89 AE 2.83%, n = 49; DH-PH: 97.43 AE 5.66%, n = 34, one-way ANOVA: F 2 , 111 = 7.583, p = 0.0008, Bonferroni's multiple comparison tests: **p < 0.01, ns: not significant) and (c) intensity (GFP: 100.00 AE 12.07%, n = 29; Asef1: 66.08 AE 2.84%, n = 49; DH-PH: 100.20 AE 11.93%, n = 34, one-way ANOVA: F 2 , 111 = 5.856, p = 0.0038, Bonferroni's multiple comparison tests: *p < 0.05, ns: not significant) of PSD-95-immunopositive puncta in dendrites were significantly decreased by Asef1 expression, but not DH-PH expression. The n value means n dendrites from three to four independent cultures. interaction between PSD-95 and Staufen was increased by the expression of wild-type or ABR-SH mutant of Asef1, which contain Stau1-binding domains, but not by DH-PH mutant, which does not contain Stau1-binding domains, indicating the interaction between Asef1 and Stau1 might affect the Staufen's ability to mediate localization of 6 and 8) .
Although neuronal activity caused Stau1 and Asef1 to be dissociated, it seemed that Stau1 was not completely released from the complex (Fig. 7) . Therefore, dissociation of Stau1 from Asef1 could be regulated by the strength or type of neuronal activity. Various growth factors, such as hepatocyte growth factor, basic fibroblast growth factor, and epidermal growth factor, can induce the formation of Asef1-APC complexes and their localization to membrane ruffles and lamellopodia, which is mediated by PI3K and the PH domain of Asef1 (Kawasaki et al. 2010) . Additionally, PI3K is essential for Asef2-mediated cell migration (Bristow et al. 2009 ). In neurons, various neurotrophins, such as brain-derived neurotrophic factor, neurotrophin 3/4 (NT-3/4), and nerve growth factor, are coupled with receptor tyrosine kinases and PI3K, and are involved in the growth and differentiation of new synapses (Huang and Reichardt 2001) . Neurotrophins might regulate the release of Stau1 through the phosphorylation of Asef1 mediated by PI3K or through the phosphorylation of Stau1 by an unidentified kinase (Fig. 8) . Alternatively, activation of the N-methyl-D-aspartate (NMDA) receptor-dependent Ca 2+ /calmodulin-dependent protein kinase II that induces the activation of PI3K, the insertion of AMPA receptors into the membrane, and long-term potentiation (Man et al. 2003; Molnar 2011 ) might regulate the release of Stau1 through the phosphorylation of Asef1 (Fig. 8) .
Although it was suggested that Staufen-mediated synaptic localization of PSD-95 protein in our study, we do not exclude the PSD-95 mRNA transport by Stau1 in the regulation of postsynaptic level of PSD-95. The synaptic delivery of PSD-95 mRNA or protein might be regulated by Staufen depending on the Asef1-binding status on it. Thus, further studies remain the fine regulatory mechanisms of PSD-95 synaptic expression by Staufen. 100.00 AE 27.62%, n = 31, total length examined: 2170 lm; +KCl: 60.01 AE 6.38%, n = 33, total length examined: 2310 lm; student's ttest: **p < 0.01), and intensity (CTL: 100.00 AE 8.40%, n = 31; +KCl: 64.75 AE 5.73%, n = 33) of PLA-positive particles. (d) Dissociation between Staufen and Asef1 is dependent on the PI3K signaling pathway (CTL: 100.00 AE 5.15%, n = 25, total length examined: 2644 lm; +KCl [LY303511]: 60.19 AE 3.53%, n = 35, total length examined: 4297 lm; +KCl [LY294002]: 86.72 AE 3.52%, n = 35, total length examined: 3778 lm; one-way ANOVA: F 2, 92 = 25.60, ****p < 0.0001; Bonferroni's multiple comparison tests: ns: not significant, ***p < 0.001). The n value means n dendrites from three to four independent cultures.
A recent study reported that Asef2, a homolog of Asef1, regulates spine formation through the actin-binding protein spinophilin and Rac1signaling, and increases PSD-95 levels in dendrites (Evans et al. 2015) . Unlike Asef1, we were unable to detect Asef2 in the brain (data not shown). Furthermore, Hamann et al. (2007) report that Asef2 expression in the brain is marginal by using northern blot analysis. Although our data are not compatible with the results of Evans et al. (2015) , our observation adds up the roles of Asef in dendritic function and structural plasticity.
In conclusion, Asef1 interacts with Stau, which are regulated by neuronal activity in a PI3K-dependent manner. This interaction reduces Stau1-mediated synaptic localization of PSD-95. Therefore, Asef1 has a role as a negative regulator for synaptic localization of PSD-95 and synaptic transmission in neurons (Fig. 8 ). All experiments were conducted in compliance with the ARRIVE guidelines.
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Supporting information
Additional supporting information may be found online in the Supporting Information section at the end of the article. Figure S1 . Asef1 expression reduces level of PSD-95, but not that of Synapsin I. Figure S2 . Asef1 expression reduces level of PSD-95, but not that of Homer 1. Figure S3 . A siRNA is specific for Asef1. (a) siRNA #1 is specific for rat Asef1. Figure S4 Reduced Asef1 expression results in increased synaptic transmission. Figure S5 Interaction between Asef1 and Staufen1 is mediated by ABR of Asef1 and RBD of Staufen1. Figure S6 Asef1 is colocalized with Staufen1 in cultured rat hippocampal neurons. Figure S7 Interaction between Stau1 and PSD-95 is increased by Asef1. Fig. 8 Model of Asef1's roles in postsynaptic compartments. Asef1 inhibits Staufen-mediated synaptic localization of PSD-95 by binding with Staufen. Neuronal activity through NMDA receptor and/or hypothetically by inducing activitydependent release of a neurotrophic factor such as brain-derived neurotrophic factor (BDNF) could activate PI3K signaling pathway and make a dissociation of Staufen from Asef1, which is required for the PSD-95 synaptic localization. Consequently, Asef1-free Staufen localizes PSD-95 to postsynaptic compartments (①) and Asef1 also functions as a GEF (②).
